XML 88 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Incentive Plan - Summary of Company's Outstanding Restricted Stock (Detail)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   71,748
Expected future remaining compensation expense | $ $ 1,078 $ 1,078
Expected future compensation expense, restricted shares remaining vesting period   2 years 4 months 9 days
Restricted Shares Awarded on April 10, 2018 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   1,470
Date of Award   Apr. 10, 2018
Expected future remaining compensation expense | $ 8 $ 8
Expected future compensation expense, restricted shares remaining vesting period   3 months
Restricted Shares Awarded on March 14, 2019 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,034
Date of Award   Mar. 14, 2019
Expected future remaining compensation expense | $ 49 $ 49
Expected future compensation expense, restricted shares remaining vesting period   1 year 3 months
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   4,304
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 21 $ 21
Expected future compensation expense, restricted shares remaining vesting period   3 months
Restricted Shares Awarded on March 14, 2020 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   6,951
Date of Award   Mar. 14, 2020
Expected future remaining compensation expense | $ 106 $ 106
Expected future compensation expense, restricted shares remaining vesting period   2 years 3 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   11,359
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 170 $ 170
Expected future compensation expense, restricted shares remaining vesting period   3 years 3 months
Restricted Shares Awarded on March 3, 2021 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   13,692
Date of Award   Mar. 03, 2021
Expected future remaining compensation expense | $ 164 $ 164
Expected future compensation expense, restricted shares remaining vesting period   1 year 3 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   12,914
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ 264 $ 264
Expected future compensation expense, restricted shares remaining vesting period   4 years 3 months
Restricted Shares Awarded on March 3, 2022 [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Granted   17,024
Date of Award   Mar. 03, 2022
Expected future remaining compensation expense | $ $ 296 $ 296
Expected future compensation expense, restricted shares remaining vesting period   2 years 3 months
Restricted Stock [Member]    
Schedule Of Nonvested Stock Option Activity [Line Items]    
Number of Restricted Shares, Nonvested at beginning of period 71,748 69,840
Number of Restricted Shares, Granted 0 31,774
Number of Restricted Shares, Vested 0 (27,728)
Number of Restricted Shares, Forfeited 0 (2,138)
Number of Restricted Shares, Nonvested at end of period 71,748 71,748
Weighted Average Grant Date Fair Value, Nonvested at beginning of period | $ / shares $ 21.88 $ 20.14
Weighted Average Grant Date Fair Value, Granted | $ / shares 0 24.51
Weighted Average Grant Date Fair Value, Vested | $ / shares 0 24.28
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 0 21.99
Weighted Average Grant Date Fair Value, Nonvested at end of period | $ / shares $ 21.88 $ 21.88